Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 157,375 | 117,947 | 74,032 | 150,807 | 151,919 |
| Receivables | 287,178 | 270,068 | 288,836 | 277,398 | 265,426 |
| Inventories | 97,101 | 93,735 | 98,097 | 90,037 | 86,055 |
| Other current assets | 62,164 | 47,286 | 84,103 | 74,453 | 110,742 |
| TOTAL | $637,391 | $559,234 | $578,661 | $629,647 | $614,142 |
| Non-Current Assets | |||||
| PPE Net | 664,437 | 677,959 | 671,673 | 680,565 | 657,601 |
| Intangibles | 496,552 | 506,259 | 695,931 | 489,790 | 482,401 |
| Other Non-Current Assets | 305,338 | 325,045 | 86,578 | 85,915 | 93,085 |
| TOTAL | $1,466,327 | $1,509,263 | $1,454,182 | $1,256,270 | $1,233,087 |
| Total Assets | $2,103,718 | $2,068,497 | $2,032,843 | $1,885,917 | $1,847,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,382 | 17,033 | 16,599 | 17,993 | 31,880 |
| Accounts payable and accrued liabilities | 43,897 | 36,675 | 31,629 | 32,967 | 34,904 |
| Accrued Expenses | 146,505 | 162,326 | 166,210 | 133,430 | 116,799 |
| Other current liabilities | 16,056 | 12,544 | 21,347 | 12,564 | 7,839 |
| TOTAL | $309,989 | $311,761 | $314,104 | $276,532 | $270,489 |
| Non-Current Liabilities | |||||
| Long Term Debt | 840,481 | 845,997 | 835,800 | 754,777 | 754,533 |
| Deferred Revenues | 80,297 | 81,343 | 76,019 | 77,382 | 76,658 |
| Other Non-Current Liabilities | 123,117 | 124,483 | 173,854 | 148,043 | 154,572 |
| TOTAL | $1,009,301 | $1,019,180 | $1,010,142 | $903,556 | $909,178 |
| Total Liabilities | $1,319,290 | $1,330,941 | $1,324,246 | $1,180,088 | $1,179,667 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,178 | 46,718 | 46,624 | 46,779 | 47,360 |
| Common Shares | 861 | 855 | 854 | 853 | 853 |
| Retained earnings | 47,681 | 10,538 | -21,346 | -58,725 | -107,234 |
| Other shareholders' equity | -138,098 | -130,797 | -116,253 | -85,984 | -104,788 |
| TOTAL | $784,428 | $737,556 | $708,597 | $705,829 | $667,562 |
| Total Liabilities And Equity | $2,103,718 | $2,068,497 | $2,032,843 | $1,885,917 | $1,847,229 |